Disappointments In Alzheimer’s Therapeutic Development — A Conversation With John LaMattina

What's the neuroscience pipeline look like in Big Pharma? … For example, Lilly has a lot of entries in neurosciences (e.g., Alzheimer's disease), and so …

Link to Full Article: Read Here